Does SEMAGLUTIDE Cause Obesity? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Obesity have been filed in association with SEMAGLUTIDE (WEGOVY). This represents 0.1% of all adverse event reports for SEMAGLUTIDE.
32
Reports of Obesity with SEMAGLUTIDE
0.1%
of all SEMAGLUTIDE reports
1
Deaths
10
Hospitalizations
How Dangerous Is Obesity From SEMAGLUTIDE?
Of the 32 reports, 1 (3.1%) resulted in death, 10 (31.3%) required hospitalization, and 1 (3.1%) were considered life-threatening.
Is Obesity Listed in the Official Label?
Yes, Obesity is listed as a known adverse reaction in the official FDA drug label for SEMAGLUTIDE.
What Other Side Effects Does SEMAGLUTIDE Cause?
Nausea (10,036)
Vomiting (6,518)
Off label use (5,425)
Diarrhoea (5,331)
Decreased appetite (4,317)
Constipation (4,036)
Weight decreased (3,518)
Impaired gastric emptying (2,622)
Product use in unapproved indication (2,613)
Wrong technique in product usage process (2,538)
What Other Drugs Cause Obesity?
RISPERIDONE (3,039)
PREDNISONE (1,880)
METHOTREXATE (1,876)
ADALIMUMAB (1,780)
TOCILIZUMAB (1,630)
ABATACEPT (1,605)
INFLIXIMAB (1,536)
HYDROXYCHLOROQUINE (1,532)
SULFASALAZINE (1,455)
ETANERCEPT (1,407)
Which SEMAGLUTIDE Alternatives Have Lower Obesity Risk?
SEMAGLUTIDE vs SEMUSTINE
SEMAGLUTIDE vs SENNA LEAF
SEMAGLUTIDE vs SENNA LEAF\SENNOSIDES\SENNOSIDES A AND B
SEMAGLUTIDE vs SENNOSIDES
SEMAGLUTIDE vs SENNOSIDES A AND B